Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cell. 2013 Aug 15;154(4):859-74. doi: 10.1016/j.cell.2013.07.031.

Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells.

Author information

  • 1Faculty of Biology, Albert-Ludwigs-University Freiburg, 79104 Freiburg, Germany. k.thedieck@umcg.nl

Erratum in

  • Cell. 2013 Nov 7;155(4):964-6.

Abstract

Mammalian target of rapamycin complex 1 (mTORC1) controls growth and survival in response to metabolic cues. Oxidative stress affects mTORC1 via inhibitory and stimulatory inputs. Whereas downregulation of TSC1-TSC2 activates mTORC1 upon oxidative stress, the molecular mechanism of mTORC1 inhibition remains unknown. Here, we identify astrin as an essential negative mTORC1 regulator in the cellular stress response. Upon stress, astrin inhibits mTORC1 association and recruits the mTORC1 component raptor to stress granules (SGs), thereby preventing mTORC1-hyperactivation-induced apoptosis. In turn, balanced mTORC1 activity enables expression of stress factors. By identifying astrin as a direct molecular link between mTORC1, SG assembly, and the stress response, we establish a unifying model of mTORC1 inhibition and activation upon stress. Importantly, we show that in cancer cells, apoptosis suppression during stress depends on astrin. Being frequently upregulated in tumors, astrin is a potential clinically relevant target to sensitize tumors to apoptosis.

Copyright © 2013 Elsevier Inc. All rights reserved.

PMID:
23953116
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk